Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Ketter, T. A., Miller, S., Dell'Osso, B., Calabrese, J. R., Frye, M. A., & Citrome, L. (2014). Balancing benefits and harms of treatments for acute bipolar depression. Journal of Affective Disorders, 169(Suppl 1), S24-S33. doi:S0165-0327(14)70006-0
Kibel, H. D. (2016). Rashomon revisited: A re-analysis of the film and implications for mass psychology. International Journal of Group Psychotherapy, 66(1), 75-101. doi:10.1080/00207284.2015.1089688
Kim, H., Kim, W., Citrome, L., Akiskal, H. S., Goffin, K. C., Miller, S., . . . Ketter, T. A. (2016). More inclusive bipolar mixed depression definition by permitting overlapping and non-overlapping mood elevation symptoms. Acta Psychiatrica Scandinavica, 134(3), 199-206. doi:10.1111/acps.12580
Kim, S. W., Jeong, B. O., Kim, J. M., Shin, I. S., Hwang, M. Y., Paul Amminger, G., . . . Yoon, J. S. (2015). Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness. Psychiatry Research, 226(1), 368-375. doi:10.1016/j.psychres.2015.01.021
Kim, S. W., Lee, J. H., Kim, J. M., Shin, I. S., Hwang, M. Y., Amminger, G. P., . . . Yoon, J. S. (2016). Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness. International Journal of Neuropsychopharmacology, 19(Suppl 1), 193. doi:10.1093/ijnp/pyw041.396
Kim, S. W., Lindenmayer, J. P., & Hwang, M. Y. (2013). Schizophrenia with obsessive-compulsive symptoms: Clinical and conceptual issues. Psychiatric Annals, 43(10), 442-445. doi:10.3928/00485713-20131003-04
Kim, W., Kim, H., Citrome, L., Akiskal, H. S., Goffin, K. C., Miller, S., . . . Ketter, T. A. (2016). More inclusive bipolar mixed depression definitions by requiring fewer non-overlapping mood elevation symptoms. Acta Psychiatrica Scandinavica, 134(3), 189-198. doi:10.1111/acps.12563
Korenis, P., & Billick, S. B. (2014). Forensic implications: Adolescent sexting and cyberbullying. The Psychiatric Quarterly, 85(1), 97-101. doi:10.1007/s11126-013-9277-z
Krayem, B. H., Dunn, N. R., & Swift, R. G. (2014). Psychosis after right temporal lobe tumor resection and recurrence. Journal of Neuropsychiatry and Clinical Neurosciences, 26(1),doi:10.1176/appi.neuropsych.13030051
Levitan, B., Markowitz, M., Mohamed, A. F., Johnson, F. R., Alphs, L., Citrome, L., & Bridges, J. F. (2015). Patients' preferences related to benefits, risks, and formulations of schizophrenia treatment. Psychiatric Services, 66(7), 719-726. doi:10.1176/appi.ps.201400188
Lindenmayer, J. P., Nasrallah, H., Pucci, M., James, S., & Citrome, L. (2013). A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities. Schizophrenia Research, 147(2-3), 241-252. doi:10.1016/j.schres.2013.03.019
Lineberry, N., Berlin, J. A., Mansi, B., Glasser, S., Berkwits, M., Klem, C., . . . Citrome, L. (2016). Recommendations to improve adverse event reporting in clinical trial publications: A joint pharmaceutical industry/journal editor perspective. BMJ, 355, i5078. doi:10.1136/bmj.i5078
Lingiardi, V., Nardelli, N., & Drescher, J. (2015). New Italian lesbian, gay and bisexual psychotherapy guidelines: A review. International Review of Psychiatry, 27(5), 405-415. doi:10.3109/09540261.2015.1064875
Loebel, A., & Citrome, L. (2015). Lurasidone: A novel antipsychotic agent for the treatment of schizophrenia and bipolar depression. BJPsych Bulletin, 39(5), 237-241. doi:10.1192/pb.bp.114.048793
Loebel, A., Citrome, L., Correll, C. U., Xu, J., Cucchiaro, J., & Kane, J. M. (2015). Treatment of early non-response in patients with schizophrenia: Assessing the efficacy of antipsychotic dose escalation. BMC Psychiatry, 15(1), 271. doi:10.1186/s12888-015-0629-0
Loebel, A., Silva, R., Goldman, R., Watabe, K., Cucchiaro, J., Citrome, L., & Kane, J. M. (2016). Lurasidone dose escalation in early nonresponding patients with schizophrenia: A randomized, placebo-controlled study. The Journal of Clinical Psychiatry, 77(12), 1672-1680. doi:10.4088/JCP.16m10698
MacEwan, J. P., Seabury, S., Aigbogun, M. S., Kamat, S., van Eijndhoven, E., Francois, C., . . . Citrome, L. (2016). Pharmaceutical innovation in the treatment of schizophrenia and mental disorders compared with other diseases. Innovations in Clinical Neuroscience, 13(7-8), 17-25. This material can be found here.
Markowitz, M. A., Levitan, B. S., Mohamed, A. F., Johnson, F. R., Bridges, J. F., Alphs, L., & Citrome, L. (2014). Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment. Psychiatric Services (Washington, D.C.), 65(9), 1133-1139. doi:10.1176/appi.ps.201300290
May, J., Osmond, K., & Billick, S. B. (2014). Juvenile delinquency treatment and prevention: A literature review. The Psychiatric Quarterly, 85(3), 295-301. doi:10.1007/s11126-014-9296-4
McEvoy, J. P., Citrome, L., Hernandez, D., Cucchiaro, J., Hsu, J., Pikalov, A., & Loebel, A. (2013). Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: A randomized, 6-week, open-label study. Journal of Clinical Psychiatry, 74(2), 170-179. doi:10.4088/JCP.12m07992
Muskin, P. R., Gerbarg, P. L., & Brown, R. P. (2013). Along roads less traveled: Complementary, alternative, and integrative treatments. Psychiatric Clinics of North America, 36(1), xiii-xv. doi:10.1016/j.psc.2013.01.009
Nahas, Z., Short, B., Burns, C., Archer, M., Schmidt, M., Prudic, J., . . . Nobler, M. S. (2013). A feasibility study of a new method for electrically producing seizures in man: Focal electrically administered seizure therapy [FEAST]. Brain Stimulation, 6(3), 403-408. doi:10.1016/j.brs.2013.03.004
Novakovic, V., Adel, T., Peselow, E. D., & Lindenmayer, J. P. (2013). Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS). Clinical Neuropharmacology, 36(2), 59-62. doi:10.1097/WNF.0b013e3182854f70
Opler, L. A., Hwang, M. Y., & Opler, M. G. (2013). Comorbidities in schizophrenia: Challenges for researchers and clinicians. Psychiatric Annals, 43(10), 438-441. doi:10.3928/00485713-20131003-03
Pahlajani, S., & Citrome, L. (2015). Liraglutide subcutaneous injection for weight loss: Where does it fit? International Journal of Clinical Practice, 69(7), 719-721. doi:10.1111/ijcp.12692
